GlucoTrack, Inc. (GCTK)
OTC: GCTK · Surgical & Medical Instruments & Apparatus · Rutherford, NJ · filing with the SEC since 2010
Who owns GlucoTrack, Inc.
As filed with the SECHolders of 5% or more
1
White Lion Capital LLC holds 9.99% of Common Stock, as its SCHEDULE 13G filed Sep 2, 2026 says.
Directors and officers
5
report now, of 21 people on the record since 2012. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
White Lion Capital LLC
SCHEDULE 13G · filed Sep 2, 2026 · Common Stock
Armistice Capital, LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 9.99% in Feb 17, 2026
Sabby Management, LLC
SCHEDULE 13G/A · filed Jan 3, 2025 · Common Stock · reported falling below 5%
Ikarian Capital, LLC
SCHEDULE 13G · filed Feb 17, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%
What GCTK reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 31, 2025.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2024 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.